


	Quick List/Search
	Pain Management Partnership
	Medication Therapy Management Services (MTMS)
	Immunizations
	Topics in Patient Care
	APhA Special Reports
	Multimedia CE Programs

CPE Quicklist

›› 2006 Self-Care Practice Update– Proceedings from the Self-Care Institute – 202-000-06-229-H04

›› 2008 Immunization Update – 202-000-08-151-H01-P

›› Achieving Optimal Therapeutic Outcomes with Oral Over-the-Counter Analgesics: Accessing Benefit Versus Risk – 202-000-08-247-H01-P

›› Advanced Practice Institute: Diabetes – Building a Successful Diabetes Practice – 202-000-07-133-H01

›› Advances in the Control of Blood Glucose in Type 2 Diabetes – 202-000-07-141-H01-P

›› APhA Pharmacy Law Matters 2008: Recent Legal and Regulatory Issues Affecting Pharmacy – 202-000-08-233-H03-P (pharmacists); 202-000-08-233-H03-T (technicians); APhA Members Only

›› APhA Pharmacy Law Matters 2009: Recent Legal and Regulatory Issues Affecting Pharmacy – 202-000-09-215-H03-P (pharmacists); 202-000-09-215-H03-T (technicians); APhA Members Only

›› APhA Preparing Pharmacists to Respond to the 2009 H1N1 Influenza – 202-000-09-233-L04-P

›› Appropriate Use of Common OTC Analgesics and Cough and Cold Medications – 202-999-08-111-H01-P

›› Cardiology Update for Pharmacists: Highlights of the 2006 American Heart Association Scientific Sessions – 202-000-07-102-H01

›› Cardiology update for pharmacists: Highlights of the 2007 American College of Cardiology Annual Conference – 202-000-07-136-H01

›› Caring for patients with celiac disease: The role of the pharmacist – 202-000-08-223-H01-P

›› Case Studies in Overactive Bladder – 202-000-09-125-L01-P

›› CE Quicklist

›› Chronic hepatitis C virus infection: A review for pharmacists – 202-000-07-139-H01

›› Collaborative practice for pharmacy-based immunization – 202-000-07-255-H01-P

›› Comparative Effectiveness Research: Relevance and Applications to Pharmacy – 202-999-09-224-L04-P

›› Comparative Effectiveness, Safety, and Indications of Insulin Analogues in Premixed Formulations for Adults With Type 2 Diabetes-Home Study – 202-999-09-111-H01-P

›› Concepts in Comprehensive Weight Management Monograph 1: Identifying and Treating Overweight and Obesity – 202-000-07-101-H01

›› Concepts in Comprehensive Weight Management Monograph 2: Behavioral Strategies for Weight Management – 202-000-07-103-H01

›› Concepts in Comprehensive Weight Management Monograph 3: Weight Loss Pharmacotherapy and the Pharmacists's Role in Weight Management – 202-000-07-134-H01

›› Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps – 202-000-09-108-H01-P

›› COPD 2009: an update for pharmacists – 202-000-09-230-H01-P

›› Coulee Region Community Pharmacy Asthma Intervention Study, The – 202-000-06-249-H04

›› Counseling and Management Strategies for the Organ Transplant Patient on Maintenance Immunosuppression – 202-000-09-127-H01-P

›› Dextromethorphan abuse: Clinical effects and management – 202-000-09-115-H01-P

›› Diabetes 2006: An Update for Pharmacists – 202-000-06-246-H01

›› Diabetes 2007: An update for pharmacists from the 67th Scientific Sessions of the American Diabetes Association – 202-000-07-213-H01-P

›› Emergency Contraception: The Pivotal Role of the Pharmacist – 202-000-07-220-H01

›› Ethics and patient privacy – 202-000-08-231-H04-P (pharmacists); 202-000-08-231-H04-T (technicians)

›› Exenatide: From the Gila Monster to the Pharmacy – 202-000-06-116-H01

›› Guiding Self-Care Product Use – 202-000-09-217-H01-P

›› Health literacy: A barrier to pharmacist–patient communication and medication adherence – 202-000-09-219-H04-P

›› How to Provide Excellent Customer Service to Your Patients – 202-000-09-123-H04-T (technicians); APhA Members Only

›› Human papillomavirus vaccine and cervical cancer prevention: Practice and policy implications for pharmacists – 202-000-07-266-H01-P

›› ICAAC 2007: Infectious Disease Update for Pharmacists – 202-000-08-101-H01-P

›› Implementing Pain Management Services in Pharmacy Practice – 202-000-06-148-H04

›› Influenza Disease and Prevention Update for Pharmacists 2007 – 202-000-07-215-H01-P

›› Inpatient to Outpatient: The Pharmacist’s Role in Improving Patient Outcomes in Venous Thromboembolism – 202-000-09-124-H01-P

›› Inpatient Treatment of Acute Coronary Syndromes: Pharmacologic Implications – 202-000-09-228-H01-P

›› Integration of temperature-controlled requirements into pharmacy practice – 202-000-09-118-H04-P

›› July 22, 2009 - Case Studies in Overactive Bladder – 202-000-09-125-L01-P

›› July 9, 2009 - Case Studies in Overactive Bladder – 202-000-09-125-L01-P

›› Keys to Success: The Role of the Pharmacist in Weight Loss Counseling - A Multimedia Program for Pharmacists – 202-000-07-114-H01

›› Lifestyle modifications for patients with hypertension – 202-000-08-147-H04-P

›› Managing oneself: An essential skill for managing others – 202-000-09-119-H04-P

›› Medication interventions for fall prevention in the older adult – 202-000-09-122-H01-P

›› Medication Therapy Management (MTM) Services: Applying Compliance and Adherence Principles to Optimize Care of Patients with Diabetes – 202-000-06-247-H04

›› Medication Therapy Management (MTM) Services: Creating a Patient Care Process – 202-000-07-258-H04-P

›› Medication Therapy Management (MTM) Services: Keys to Success in Helping Patients with Heart Failure – 202-000-07-118-H01

›› Medication Therapy Management Services: Applying Core Elements of MTM to Optimize Care of Patients With Early Parkinson’s Disease – 202-000-08-221-H01-P

›› Medication Therapy Management Services: Applying Principles to Optimize Care of Patients With Alzheimer’s Disease – 202-000-08-232-H01-P

›› Medication Therapy Management Services: Applying Principles to Optimize Care of Patients With Chronic Obstructive Pulmonary Disease – 202-000-08-102-H01-P

›› Medication Therapy Management Services: Applying Principles to Optimize Care of Patients With Overactive Bladder – 202-000-09-218-H01-P

›› Medication Therapy Management Services: Developing a Practice as an Independent MTM Pharmacist – 202-000-08-235-H03-P; APhA Members Only

›› Medication Therapy Management Services: Documenting Pharmacy-Based Patient Care Services – 202-000-07-268-H04-P

›› Medication Therapy Management Services: Identifying and Addressing Medication Adherence Issues – 202-000-08-145-H04-P

›› Medication Therapy Management Services: Opportunities for Pharmacists to Improve Medication Adherence in Patients With Chronic Obstructive Pulmonary Disease – 202-000-08-153-H04-P

›› Migraine-preventive medications: Ensuring their appropriate use – 202-000-08-152-H01-P

›› National e-Prescribing Conference: e-Prescribing & Medicare Part D: Looking at Standards & Certification – 202-999-08-236-H04-P

›› National e-Prescribing Conference: Implementing e-Prescribing: The Basics – 202-999-08-238-H04-P

›› National e-Prescribing Conference: Learning from Experience: Pharmacists – 202-999-08-238-H04-P

›› National e-Prescribing Conference: Medicaid & e-Prescribing – 202-999-08-240-H04-P

›› National e-Prescribing Conference: Privacy, Security & Risk Management – 202-999-08-241-H04-P

›› National e-Prescribing Conference: Promoting e-Prescribing in Your State: Getting Policymakers on Board – 202-999-08-242-H04-P

›› National e-Prescribing Conference: The How-To’s of e-Prescribing Promotion Initiatives: Methods & Real-World Experiences in E-prescribing – 202-999-08-237-H04-P

›› National e-Prescribing Conference: Value for Consumers: What are the Benefits of e-Prescribing to Them? – 202-999-08-243-H04-P

›› National e-Prescribing Conference: Working Together to Implement e-Prescribing – 202-999-08-244-H01-P

›› New Advances in Influenza Vaccination—A Multimedia CE Program for Pharmacists – 202-000-08-154-H01-P

›› New Therapeutic Agents Marketed in the First Half of 2006 – 202-000-06-253-H01

›› New Therapeutic Agents Marketed in the First Half of 2007 – 202-000-07-237-H01-P

›› New Therapeutic Agents Marketed in the First Half of 2008 – 202-000-08-225-H01-P

›› New Therapeutic Agents Marketed in the First Half of 2009: Part 1 – 202-000-09-226-H01-P

›› New Therapeutic Agents Marketed in the First Half of 2009: Part 2 – 202-000-09-230-H01-P

›› New Therapeutic Agents Marketed in the Second Half of 2006 – 202-000-07-115-H01

›› New Therapeutic Agents Marketed in the Second Half of 2007 – 202-000-08-109-H01-P

›› New Therapeutic Agents Marketed in the Second Half of 2008 – 202-000-09-110-H01-P

›› New Vaccines and Guidelines for Their Use – 202-000-07-140-H01

›› Optimizing Adherence to HIV/AIDS Medication Regimens – 202-000-09-120-H02-P

›› Overcoming Race-Based Disparities in Pain Management – 202-000-08-224-H01-P

›› Pharmacist's Role in Opioid Addiction Management, The – 202-000-08-104-H01-P

›› Pharmacists’ considerations when serving Amish patients – 202-000-08-246-H04-P

›› Pharmacotherapy for Pain Management: New Treatment Approaches – 202-000-08-222-H01-P

›› Potential Roles for Pharmacists in Pharmacogenetics – 202-999-08-103-H01-P

›› Preventing Common Drug Therapy Problems Involving Pediatric Cough and Cold Medications – 202-000-09-223-H01-P

›› Proceedings of the 2007 Self-Care Institute – 202-000-07-214-H04

›› Providing Pharmaceutical Care to Patients with ADHD – 202-000-07-254-H01-P

›› Role of calcium channel blockers in treatment of hypertension – 202-000-08-110-H01-P

›› Role of Nonprescription Antihistamines in the Treatment of Allergic Rhinitis, The – 202-999-07-267-H01-P

›› Role of the Pharmacist in Adolescent and Adult Immunization, The – 202-000-07-138-H04

›› Roles for pharmacy in combating counterfeit drugs – 202-000-08-146-H03-P

›› Safety issues associated with commercially available energy drinks – 202-000-08-142-H01-P

›› Schizophrenia: Optimal therapy with second-generation antipsychotic agents – 202-000-07-259-H01-P

›› Selective serotonin reuptake inhibitor–induced akathisia – 202-000-09-116-H01-P

›› Sharpen Your Immunization Knowledge – 202-000-09-216-H01-P

›› Sorting Out the Options for Self-Treatment of Heartburn and Dyspepsia – 202-000-06-250-H01

›› Special Report: 2009 H1N1 Influenza – An Update for Pharmacists – 202-000-09-232-H01-P

›› Strategies for Implementing a Pharmacy-Based Travel Health and Vaccine Service—2008 Update: A Multimedia CE Program for Pharmacists – 202-000-08-113-H01-P

›› Strategies for Successful Management of Enlarged Prostate – 202-000-06-152-H01

›› Supporting Patient Self-Care for Osteoarthritis – 202-000-08-143-H04-P

›› Supporting Patients With Overactive Bladder – 202-000-09-113-H01-P

›› Treatment of Acute Diarrhea in Adults: Sorting Out the Options – 202-000-09-117-H01-P

›› Understanding the impact of overactive bladder from a patient perspective – 202-000-09-114-H01-P

›› Understanding the Prevalence of Migraines: Diagnosis, Disease and Treatment – 202-000-07-119-H01

›› Update for pharmacists: The 2007 American Diabetes Association standards of medical care in diabetes – 202-000-07-117-H01

›› Using Relationship Marketing to Expand Pharmacy Services – 202-000-07-261-H04-P

›› Vaccine supply, demand, and policy: A primer – 202-000-09-209-H04-P

›› What Parents Need to Know About the Common Cold – 202-000-09-222-H01-P

›› What's New in Breast Cancer and Hematologic Malignancy Treatment – 202-000-07-112-H01

›› What’s New in the Pharmacologic Management of Cardiovascular Disease? – 202-000-09-225-H01-P

›› Writing a Business Plan for a New Pharmacy Service – 202-000-07-260-H04-P